PVI
REGN icon

Pura Vida Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Pura Vida Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50,000
Closed -$13.9M – 114
2019
Q3 		$13.9M Buy
+50,000
New +$14.8M 2.37% 13
2018
Q4 		– Sell
-10,000
Closed -$4.04M – 104
2018
Q3 		$4.04M Buy
+10,000
New +$3.81M 0.85% 35

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Pura Vida Investments's REGN Position: Q3 2021 in Review

Pura Vida Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 10,000 shares — an estimated $5.58M sold.

Pura Vida Investments first reported a position in REGN in Q4 2017 and held it in 5 quarters. The position peaked at $11.1M in Q3 2019. 1,018 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Pura Vida Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 10,000 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $5.58M.
  • Pura Vida Investments first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Pura Vida Investments's Regeneron Pharmaceuticals position peaked at $11.1M in Q3 2019.
  • 1,018 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.